About this trial
1. The aim of this large scale study to survey the prevalence of nutritional risk and malnutrition in China,Europe and USA. 2. The impact of nutritional support for the patients at nutritional risk on clinical outcomes and cost-effectiveness
Already get the approval by Ethics Committee of Peking Union medical college and Johns Hopkins Hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients be in hospital overnight
diagnoses according to the protocol of cohort study for cost effectiveness
Disqualifiers
patients admitting from emergency department
patients who undergone operation before second morning of hospitalization
patients who dose not give Informed Consents
Trial population
Continuing sampling in 6 clinical Departments of large, middle \& small size hospitals in 15 large cities from West, Middle \& East China. Also, data from Denmark and USA will be collected and analysed.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Infectious complication
A infectious complication was defined as as the presence of recognized pathogens in body tissues that normally are sterile, confirmed by the results of culture and supported by clinical, radiologic or hematologic evidence of infection
Secondary outcomes
cost effectiveness
The cost effectiveness analysis was performed from the payers' perspective.The percentage of infectious complication-free patients was used to measure the effectiveness. The total cost was considered to contain 3 items in our study. The first item was the cost of nutrition support, including nutrition solutions, nursing, physician, and other staff supervision of nutrition support preparation, administration, and catheter placement and maintenance. The second item was the cost of the infectious complication.The third item was 'other costs' associated with the hospital admission, calculated from the total costs from which the cost of nutrition support and infectious complications were subtracted. The incremental cost-effectiveness ratio (ICER) was calculated by dividing the costs difference between the nutrition support cohort and no-nutrition support cohort by their difference in effectiveness.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.